EFMH
RVMD icon

E Fund Management (HK)’s Revolution Medicines RVMD Stock Holding History

E Fund Management (HK)’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$38.8K Buy
207
+61
+42% +$8.91K 0.01% 212
2026
Q1 		$14.2K Buy
+146
New +$14.7K 0.01% 275

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

E Fund Management (HK)'s RVMD Position: Q2 2026 in Review

E Fund Management (HK) increased its Revolution Medicines (RVMD) stake by 42% in Q2 2026, buying an estimated $8.91K and bringing the position to 207 shares worth $38.8K. The position accounts for 0.01% of the portfolio, ranked #212.

E Fund Management (HK) first reported a position in RVMD in Q1 2026 and has held it in 2 quarters since. 692 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • E Fund Management (HK) held 207 shares of Revolution Medicines worth $38.8K as of Q2 2026.
  • E Fund Management (HK) bought 61 Revolution Medicines shares in Q2 2026, an estimated $8.91K.
  • Revolution Medicines made up 0.01% of E Fund Management (HK)'s portfolio in Q2 2026, its #212 holding.
  • E Fund Management (HK) first reported a position in Revolution Medicines in Q1 2026 and has held it in 2 quarters since.
  • 692 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on E Fund Management (HK)'s 13F filing for Q2 2026, filed 22 Jul 2026.